Relations of symptomatology and social functioning in patients with schizophrenia Şizofreni tanili hastalarda semptomatolojinin sosyal i̇şlevsellik üzerine etkisi


Tatlidil E., Yilmaz A., GÖĞÜŞ A. K.

Klinik Psikofarmakoloji Bulteni, cilt.19, sa.SUPPL. 1, 2009 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 19 Sayı: SUPPL. 1
  • Basım Tarihi: 2009
  • Dergi Adı: Klinik Psikofarmakoloji Bulteni
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Anahtar Kelimeler: Schizophrenia, Side-effect, Social functioning, Symptoms
  • Ankara Üniversitesi Adresli: Evet

Özet

Introduction: Despite advances in the treatment of schizophrenia and shortened hospitalization times, the majority of schizophrenia patients suffer important losses in social and occupational areas. Literature reveals some studies that show correlations between social functioning of schizophrenia patients and positive-negative, cognitive, and affective symptoms of the disease, and side-effects of antipsychotic drugs and some studies that have found no correlations between these parameters. This study aimed to investigate correlations between social functioning of schizophrenia patients, which has increasingly become the focus of treatment, and positive and negative symptoms, presence of obsessive compulsive symptoms and side effects of drugs. Method: The study was performed on 44 patients who were diagnosed with schizophrenia according to the results of structured clinical interview for DSM-IV axis-I disorders. After the patients were applied Scale for the Assessment of Positive Symptoms (SAPS), Scale for the Assessment of Negative Symptoms (SANS), Calgary Depression Scale for Schizophrenia (CDSS), and UKU Side Effect Rating Scale, they were evaluated by using self-evaluation scales of Maudsley Obsessive Compulsive Questionnaire (MOCQ) and Social Functioning Scale (SFS). Results: No statistically significant correlations were determined between the sociodemographic variables such as disease duration, marital status, living alone or with the family, gender, educational status, and social functions of the patients (p>0.05). No correlations were determined between MOCQ scores only and any of the social functionality areas (p>0.05) in the evaluation of the correlations between the SANS, SAPS, CDSS, UKU Side Effect Rating Scale, MOCQ scores and social functioning. Discussion: Management of psychopathological symptoms of schizophrenia patients in the treatment is not sufficient; state of well-being and improvements in social functioning are the indispensable dimensions of the treatment, and they should be evaluated parameters independent of negative and positive symptoms.